ARTICLE | Company News
Gilead sales and marketing update
September 3, 2002 7:00 AM UTC
GILD selected Hepsera as the trade name for its adefovir dipivoxil oral nucleotide analog to treat chronic hepatitis B virus (HBV) infection. The product was recommended for approval last month by FD...